Search

Your search keyword '"Nipp, Ryan D."' showing total 511 results
Start Over Author "Nipp, Ryan D."
511 results on '"Nipp, Ryan D."'

3. Clinical Outcomes, Treatment Toxicity, and Health Care Utilization in Older Adults with Aggressive Non‐Hodgkin Lymphoma

Author

Johnson, P Connor, Yi, Alisha, Horick, Nora, Amonoo, Hermioni L, Newcomb, Richard A, Lavoie, Mitchell W, Rice, Julia, Reynolds, Matthew J, Ritchie, Christine S, Nipp, Ryan D, and El‐Jawahri, Areej

Subjects
Patient Safety, Aging, Hematology, Cancer, Rare Diseases, Clinical Research, Lymphoma, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Aged, Female, Hospitalization, Humans, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Male, Patient Acceptance of Health Care, Retrospective Studies, Elderly, Health care utilization, Non-Hodgkin lymphoma, Survival, Toxicities, Oncology and Carcinogenesis, Oncology & Carcinogenesis
Abstract

BackgroundAlthough balancing treatment efficacy with risks of complications is critical for older adults with aggressive non-Hodgkin lymphoma (NHL), few studies have described these patients' clinical outcomes, rates of toxicities, and health care utilization.MethodsWe conducted a retrospective analysis of adults ≥65 years diagnosed with aggressive NHL and receiving systemic therapy at Massachusetts General Hospital from April 2000 to July 2020. We abstracted patient characteristics, clinical outcomes, treatment toxicity, unplanned hospitalizations, and intensive care unit (ICU) admissions within 6 months of treatment initiation from the medical record. Using multivariable logistic regression, we examined factors associated with rates of grade 3+ nonhematologic toxicity and unplanned hospitalization.ResultsAmong 295 patients (median age, 73 years; 39.0% female), 5-year overall survival (OS) was 74.2%. Five-year OS by age group (65-69, 70-74, 75-79, and 80+ years) was 82.2%, 72.0%, 73.6%, and 66.4%, respectively. Overall, 42.4% experienced grade 3+ toxicity, with 8.1% experiencing grades 4-5. The rates of unplanned hospitalization and ICU admission were 41.0% and 6.1%, respectively. In multivariable analysis, hypoalbuminemia (odds ratio [OR], 4.29; p

Published
2021

4. Leveraging patient‐reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience

Author

Gupta, Arjun, Khalid, Omar, Moravek, Cassadie, Lamkin, Anica, Matrisian, Lynn M, Doss, Sudheer, Denlinger, Crystal S, Coveler, Andrew L, Weekes, Colin D, Roeland, Eric J, Hendifar, Andrew E, and Nipp, Ryan D

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Rare Diseases, Pancreatic Cancer, Cancer, Prevention, Digestive Diseases, Management of diseases and conditions, 7.1 Individual care needs, Adult, Advertising, Aged, Aged, 80 and over, Cancer Care Facilities, Feasibility Studies, Female, Humans, Male, Middle Aged, Pancreatic Neoplasms, Patient Participation, Patient Reported Outcome Measures, Precision Medicine, Registries, Research, United States, Young Adult, PanCAN, pancreatic cancer, patient-reported outcomes, registry, Biochemistry and Cell Biology, Oncology and carcinogenesis
Abstract

BackgroundThe Pancreatic Cancer Action Network (PanCAN) Patient Registry is an online, pancreatic cancer-specific, global registry enabling patients to self-report sociodemographics, disease/management characteristics, and patient-reported outcomes (PROs). We sought to describe the creation, user experience, and research potential of the PanCAN Registry.MethodsWe obtained data to describe (1) the creation of the Registry (questionnaire development, marketing efforts, and regulatory considerations); (2) the user experience (user characteristics and interactions with the registry following inception); and (3) the research potential of the registry (comparing PROs and treatment patterns by age [±65 years] and treatment site [community or academic] for users with de novo metastatic disease).ResultsThe Registry was conceived as part of PanCAN's strategic plan for a personalized therapy initiative. PanCAN staff and disease expert consultants developed questionnaires hosted on an electronic PRO platform. Users had the option to include their data in research efforts, and the Registry platform received institutional review board approval. From 7/2015 to 12/2020, 2187 patients visited the registry and 1697 (77.6%) completed at least one survey (median age = 64 years [range: 24-90], 47.9% women, 88.7% White, 34.0% metastatic disease). Among patients with metastatic disease (N = 567), 46.0% were ≥65 years old and 67.5% received treatment at community sites. Patients ≥65 years reported feeling less hopeful about the treatment plan (12.4% vs. 24.3%, p = 0.003), and patients treated at community sites reported more frequent treatment breaks of >2 weeks (58.2% vs. 28.1%, p

Published
2021

8. Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemia

Author

Johnson, P. Connor, Woyach, Jennifer A., Ulrich, Angela, Marcotte, Veronique, Nipp, Ryan D., Lage, Daniel E., Nelson, Ashley M., Newcomb, Richard A., Rice, Julia, Lavoie, Mitchell W., Ritchie, Christine S., Bartlett, Nancy, Stephens, Deborah M., Ding, Wei, Owen, Carolyn, Stone, Richard, Ruppert, Amy S., Mandrekar, Sumithra J., Byrd, John C., El-Jawahri, Areej, Le-Rademacher, Jennifer, and Rosko, Ashley

Published
2023
Full Text
View/download PDF

12. Effects of a perioperative geriatric intervention for older adults with Cancer: A randomized clinical trial

Author

Nipp, Ryan D., Qian, Carolyn L., Knight, Helen P., Ferrone, Cristina R., Kunitake, Hiroko, Castillo, Carlos Fernandez-del, Lanuti, Michael, Qadan, Motaz, Ricciardi, Rocco, Lillemoe, Keith D., Temel, Brandon, Hashmi, Ardeshir Z., Scott, Erin, Stevens, Erin, Williams, Grant R., Fong, Zhi Ven, O'Malley, Terrence A., Franco-Garcia, Esteban, Horick, Nora K., Jackson, Vicki A., Greer, Joseph A., El-Jawahri, Areej, and Temel, Jennifer S.

Published
2022
Full Text
View/download PDF

14. Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial

Author

Parikh, Aparna R., Szabolcs, Annamaria, Allen, Jill N., Clark, Jeffrey W., Wo, Jennifer Y., Raabe, Michael, Thel, Hannah, Hoyos, David, Mehta, Arnav, Arshad, Sanya, Lieb, David J., Drapek, Lorraine C., Blaszkowsky, Lawrence S., Giantonio, Bruce J., Weekes, Colin D., Zhu, Andrew X., Goyal, Lipika, Nipp, Ryan D., Dubois, Jon S., Van Seventer, Emily E., Foreman, Bronwen E., Matlack, Lauren E., Ly, Leilana, Meurer, Jessica A., Hacohen, Nir, Ryan, David P., Yeap, Beow Y., Corcoran, Ryan B., Greenbaum, Benjamin D., Ting, David T., and Hong, Theodore S.

Published
2021
Full Text
View/download PDF

20. Supportive Oncology Care at Home Intervention for Patients With Pancreatic Cancer

Author

Nipp, Ryan D., Gaufberg, Eva, Vyas, Charu, Azoba, Chinenye, Qian, Carolyn L., Jaggers, Jordon, Weekes, Colin D., Allen, Jill N., Roeland, Eric J., Parikh, Aparna R., Miller, Laurie, Wo, Jennifer Y., Smith, Melissa Hennessey, Brown, Patricia M.C., Shulman, Eliza, Fernandez-del Castillo, Carlos, Kimmelman, Alec C., Ting, David, Hong, Theodore S., Greer, Joseph A., Ryan, David P., Temel, Jennifer S., and El-Jawahri, Areej

Published
2022
Full Text
View/download PDF

25. Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer

Author

Jarnagin, Joy X., primary, Saraf, Anurag, additional, Baiev, Islam, additional, Chi, Gary, additional, van Seventer, Emily E., additional, Mojtahed, Amirkasra, additional, Allen, Jill N., additional, Clark, Jeffrey W., additional, Blaszkowsky, Lawrence, additional, Giantonio, Bruce J., additional, Weekes, Colin D., additional, Klempner, Samuel J., additional, Franses, Joseph W., additional, Roeland, Eric J., additional, Goyal, Lipika, additional, Siravegna, Giulia, additional, Horick, Nora, additional, Corcoran, Ryan B., additional, Nipp, Ryan D., additional, and Parikh, Aparna R., additional

Published
2023
Full Text
View/download PDF

28. Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal Cancer

Author

Kanter, Katie, Fish, Madeleine, Mauri, Gianluca, Horick, Nora K., Allen, Jill N., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Ryan, David P., Nipp, Ryan D., Giantonio, Bruce J., Goyal, Lipika, Dubois, Jon, Murphy, Janet E., Franses, Joseph, Klempner, Samuel J., Roeland, Eric J., Weekes, Colin D., Wo, Jennifer Y., Hong, Theodore S., Van Seventer, Emily E., Corcoran, Ryan B., and Parikh, Aparna R.

Published
2021
Full Text
View/download PDF

32. Care Delivery Interventions for Individuals with Cancer: A Literature Review and Focus on Gastrointestinal Malignancies.

Author

Lam, Anh B., Moore, Vanessa, and Nipp, Ryan D.

Subjects
GASTROINTESTINAL tumors treatment, MEDICAL quality control, HOME care services, MEDICAL care, HEALTH outcome assessment, CANCER patients, QUALITY assurance, QUALITY of life, INTERPROFESSIONAL relations, CANCER patient medical care, PALLIATIVE treatment
Abstract

Background: Gastrointestinal malignancies represent a particularly challenging condition, often requiring a multidisciplinary approach to management in order to meet the unique needs of these individuals and their caregivers. Purpose: In this literature review, we sought to describe care delivery interventions that strive to improve the quality of life and care for patients with a focus on gastrointestinal malignancies. Conclusion: We highlight patient-centered care delivery interventions, including patient-reported outcomes, hospital-at-home interventions, and other models of care for individuals with cancer. By demonstrating the relevance and utility of these different care models for patients with gastrointestinal malignancies, we hope to highlight the importance of developing and testing new interventions to address the unique needs of this population. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Supplementary Table S2 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers

Author

Parikh, Aparna R., primary, Mojtahed, Amikasra, primary, Schneider, Jaime L., primary, Kanter, Katie, primary, Van Seventer, Emily E., primary, Fetter, Isobel J., primary, Thabet, Ashraf, primary, Fish, Madeleine G., primary, Teshome, Bezaye, primary, Fosbenner, Kathryn, primary, Nadres, Brandon, primary, Shahzade, Heather A., primary, Allen, Jill N., primary, Blaszkowsky, Lawrence S., primary, Ryan, David P., primary, Giantonio, Bruce, primary, Goyal, Lipika, primary, Nipp, Ryan D., primary, Roeland, Eric, primary, Weekes, Colin D., primary, Wo, Jennifer Y., primary, Zhu, Andrew X., primary, Dias-Santagata, Dora, primary, Iafrate, A. John, primary, Lennerz, Jochen K., primary, Hong, Theodore S., primary, Siravegna, Giulia, primary, Horick, Nora, primary, Clark, Jeffrey W., primary, and Corcoran, Ryan B., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Data from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers

Author

Parikh, Aparna R., primary, Mojtahed, Amikasra, primary, Schneider, Jaime L., primary, Kanter, Katie, primary, Van Seventer, Emily E., primary, Fetter, Isobel J., primary, Thabet, Ashraf, primary, Fish, Madeleine G., primary, Teshome, Bezaye, primary, Fosbenner, Kathryn, primary, Nadres, Brandon, primary, Shahzade, Heather A., primary, Allen, Jill N., primary, Blaszkowsky, Lawrence S., primary, Ryan, David P., primary, Giantonio, Bruce, primary, Goyal, Lipika, primary, Nipp, Ryan D., primary, Roeland, Eric, primary, Weekes, Colin D., primary, Wo, Jennifer Y., primary, Zhu, Andrew X., primary, Dias-Santagata, Dora, primary, Iafrate, A. John, primary, Lennerz, Jochen K., primary, Hong, Theodore S., primary, Siravegna, Giulia, primary, Horick, Nora, primary, Clark, Jeffrey W., primary, and Corcoran, Ryan B., primary

Published
2023
Full Text
View/download PDF

37. Data from Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

Author

Parikh, Aparna R., primary, Van Seventer, Emily E., primary, Siravegna, Giulia, primary, Hartwig, Anna V., primary, Jaimovich, Ariel, primary, He, Yupeng, primary, Kanter, Katie, primary, Fish, Madeleine G., primary, Fosbenner, Kathryn D., primary, Miao, Benchun, primary, Phillips, Susannah, primary, Carmichael, John H., primary, Sharma, Nihaarika, primary, Jarnagin, Joy, primary, Baiev, Islam, primary, Shah, Yojan S., primary, Fetter, Isobel J., primary, Shahzade, Heather A., primary, Allen, Jill N., primary, Blaszkowsky, Lawrence S., primary, Clark, Jeffrey W., primary, Dubois, Jon S., primary, Franses, Joseph W., primary, Giantonio, Bruce J., primary, Goyal, Lipika, primary, Klempner, Samuel J., primary, Nipp, Ryan D., primary, Roeland, Eric J., primary, Ryan, David P., primary, Weekes, Colin D., primary, Wo, Jennifer Y., primary, Hong, Theodore S., primary, Bordeianou, Liliana, primary, Ferrone, Cristina R., primary, Qadan, Motaz, primary, Kunitake, Hiroko, primary, Berger, David, primary, Ricciardi, Rocco, primary, Cusack, James C., primary, Raymond, Victoria M., primary, Talasaz, AmirAli, primary, Boland, Genevieve M., primary, and Corcoran, Ryan B., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Methods from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers

Author

Parikh, Aparna R., primary, Mojtahed, Amikasra, primary, Schneider, Jaime L., primary, Kanter, Katie, primary, Van Seventer, Emily E., primary, Fetter, Isobel J., primary, Thabet, Ashraf, primary, Fish, Madeleine G., primary, Teshome, Bezaye, primary, Fosbenner, Kathryn, primary, Nadres, Brandon, primary, Shahzade, Heather A., primary, Allen, Jill N., primary, Blaszkowsky, Lawrence S., primary, Ryan, David P., primary, Giantonio, Bruce, primary, Goyal, Lipika, primary, Nipp, Ryan D., primary, Roeland, Eric, primary, Weekes, Colin D., primary, Wo, Jennifer Y., primary, Zhu, Andrew X., primary, Dias-Santagata, Dora, primary, Iafrate, A. John, primary, Lennerz, Jochen K., primary, Hong, Theodore S., primary, Siravegna, Giulia, primary, Horick, Nora, primary, Clark, Jeffrey W., primary, and Corcoran, Ryan B., primary

Published
2023
Full Text
View/download PDF

39. Supplementary Tables from Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

Author

Parikh, Aparna R., primary, Van Seventer, Emily E., primary, Siravegna, Giulia, primary, Hartwig, Anna V., primary, Jaimovich, Ariel, primary, He, Yupeng, primary, Kanter, Katie, primary, Fish, Madeleine G., primary, Fosbenner, Kathryn D., primary, Miao, Benchun, primary, Phillips, Susannah, primary, Carmichael, John H., primary, Sharma, Nihaarika, primary, Jarnagin, Joy, primary, Baiev, Islam, primary, Shah, Yojan S., primary, Fetter, Isobel J., primary, Shahzade, Heather A., primary, Allen, Jill N., primary, Blaszkowsky, Lawrence S., primary, Clark, Jeffrey W., primary, Dubois, Jon S., primary, Franses, Joseph W., primary, Giantonio, Bruce J., primary, Goyal, Lipika, primary, Klempner, Samuel J., primary, Nipp, Ryan D., primary, Roeland, Eric J., primary, Ryan, David P., primary, Weekes, Colin D., primary, Wo, Jennifer Y., primary, Hong, Theodore S., primary, Bordeianou, Liliana, primary, Ferrone, Cristina R., primary, Qadan, Motaz, primary, Kunitake, Hiroko, primary, Berger, David, primary, Ricciardi, Rocco, primary, Cusack, James C., primary, Raymond, Victoria M., primary, Talasaz, AmirAli, primary, Boland, Genevieve M., primary, and Corcoran, Ryan B., primary

Published
2023
Full Text
View/download PDF

40. Supplementary Figures from Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

Author

Parikh, Aparna R., primary, Van Seventer, Emily E., primary, Siravegna, Giulia, primary, Hartwig, Anna V., primary, Jaimovich, Ariel, primary, He, Yupeng, primary, Kanter, Katie, primary, Fish, Madeleine G., primary, Fosbenner, Kathryn D., primary, Miao, Benchun, primary, Phillips, Susannah, primary, Carmichael, John H., primary, Sharma, Nihaarika, primary, Jarnagin, Joy, primary, Baiev, Islam, primary, Shah, Yojan S., primary, Fetter, Isobel J., primary, Shahzade, Heather A., primary, Allen, Jill N., primary, Blaszkowsky, Lawrence S., primary, Clark, Jeffrey W., primary, Dubois, Jon S., primary, Franses, Joseph W., primary, Giantonio, Bruce J., primary, Goyal, Lipika, primary, Klempner, Samuel J., primary, Nipp, Ryan D., primary, Roeland, Eric J., primary, Ryan, David P., primary, Weekes, Colin D., primary, Wo, Jennifer Y., primary, Hong, Theodore S., primary, Bordeianou, Liliana, primary, Ferrone, Cristina R., primary, Qadan, Motaz, primary, Kunitake, Hiroko, primary, Berger, David, primary, Ricciardi, Rocco, primary, Cusack, James C., primary, Raymond, Victoria M., primary, Talasaz, AmirAli, primary, Boland, Genevieve M., primary, and Corcoran, Ryan B., primary

Published
2023
Full Text
View/download PDF

42. Identifying Early-Phase Clinical Trial Participants at Risk for Experiencing Worse Clinical Outcomes

Author

Lundquist, Debra M., primary, Jimenez, Rachel, additional, Durbin, Sienna, additional, Horick, Nora, additional, Healy, Megan, additional, Johnson, Andrew, additional, Bame, Viola, additional, Capasso, Virginia, additional, McIntyre, Casandra, additional, Cashavelly, Barbara, additional, Juric, Dejan, additional, and Nipp, Ryan D., additional

Published
2023
Full Text
View/download PDF

44. Effect of a Symptom Monitoring Intervention for Patients Hospitalized With Advanced Cancer: A Randomized Clinical Trial

Author

Nipp, Ryan D., Horick, Nora K., Qian, Carolyn L., Knight, Helen P., Kaslow-Zieve, Emilia R., Azoba, Chinenye C., Elyze, Madeleine, Landay, Sophia L., Kay, Paul S., Ryan, David P., Jackson, Vicki A., Greer, Joseph A., El-Jawahri, Areej, and Temel, Jennifer S.

Subjects
Adult, Hospitalization, Male, Cancer Research, Oncology, Neoplasms, Humans, Female, Self Report, Anxiety, Middle Aged, Original Investigation
Abstract

IMPORTANCE: Symptom monitoring interventions are increasingly becoming the standard of care in oncology, but studies assessing these interventions in the hospital setting are lacking. OBJECTIVE: To evaluate the effect of a symptom monitoring intervention on symptom burden and health care use among hospitalized patients with advanced cancer. DESIGN, SETTING, AND PARTICIPANTS: This nonblinded randomized clinical trial conducted from February 12, 2018, to October 30, 2019, assessed 321 hospitalized adult patients with advanced cancer and admitted to the inpatient oncology services of an academic hospital. Data obtained through November 13, 2020, were included in analyses, and all analyses assessed the intent-to-treat population. INTERVENTIONS: Patients in both the intervention and usual care groups reported their symptoms using the Edmonton Symptom Assessment System (ESAS) and the 4-item Patient Health Questionnaire-4 (PHQ-4) daily via tablet computers. Patients assigned to the intervention had their symptom reports displayed during daily oncology rounds, with alerts for moderate, severe, or worsening symptoms. Patients assigned to usual care did not have their symptom reports displayed to their clinical teams. MAIN OUTCOMES AND MEASURES: The primary outcome was the proportion of days with improved symptoms, and the secondary outcomes were hospital length of stay and readmission rates. Linear regression was used to evaluate differences in hospital length of stay. Competing-risk regression (with death treated as a competing event) was used to compare differences in time to first unplanned readmission within 30 days. RESULTS: From February 12, 2018, to October 30, 2019, 390 patients (76.2% enrollment rate) were randomized. Study analyses to assess change in symptom burden included 321 of 390 patients (82.3%) who had 2 or more days of symptom reports completed (usual care, 161 of 193; intervention, 160 of 197). Participants had a mean (SD) age of 63.6 (12.8) years and were mostly male (180; 56.1%), self-reported as White (291; 90.7%), and married (230; 71.7%). The most common cancer type was gastrointestinal (118 patients; 36.8%), followed by lung (60 patients; 18.7%), genitourinary (39 patients; 12.1%), and breast (29 patients; 9.0%). No significant differences were detected between the intervention and usual care for the proportion of days with improved ESAS-physical (unstandardized coefficient [B] = −0.02; 95% CI, –0.10 to 0.05; P = .56), ESAS-total (B = −0.05; 95% CI, –0.12 to 0.02; P = .17), PHQ-4–depression (B = −0.02; 95% CI, –0.08 to 0.04; P = .55), and PHQ-4–anxiety (B = −0.04; 95% CI, –0.10 to 0.03; P = .29) symptoms. Intervention patients also did not differ significantly from patients receiving usual care for the secondary end points of hospital length of stay (7.59 vs 7.47 days; B = 0.13; 95% CI, –1.04 to 1.29; P = .83) and 30-day readmission rates (26.5% vs 33.8%; hazard ratio, 0.73; 95% CI, 0.48-1.09; P = .12). CONCLUSIONS AND RELEVANCE: This randomized clinical trial found that for hospitalized patients with advanced cancer, the assessed symptom monitoring intervention did not have a significant effect on patients’ symptom burden or health care use. These findings do not support the routine integration of this type of symptom monitoring intervention for hospitalized patients with advanced cancer. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03396510

Published
2023

45. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX

Author

Michelakos, Theodoros, Pergolini, Ilaria, Castillo, Carlos Fernández-del, Honselmann, Kim C., Cai, Lei, Deshpande, Vikram, Wo, Jennifer Y., Ryan, David P., Allen, Jill N., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Murphy, Janet E., Nipp, Ryan D., Parikh, Aparna, Qadan, Motaz, Warshaw, Andrew L., Hong, Theodore S., Lillemoe, Keith D., and Ferrone, Cristina R.

Published
2019
Full Text
View/download PDF

47. The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer

Author

Bhatt, Sunil, primary, Johnson, P Connor, additional, Markovitz, Netana H, additional, Gray, Tamryn, additional, Nipp, Ryan D, additional, Ufere, Nneka, additional, Rice, Julia, additional, Reynolds, Matthew J, additional, Lavoie, Mitchell W, additional, Clay, Madison A, additional, Lindvall, Charlotta, additional, and El-Jawahri, Areej, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results